G1 Therapeutics Inc.

NASDAQ: GTHX · Real-Time Price · USD
7.16
0.01 (0.14%)
At close: Sep 17, 2024, 9:56 PM

G1 Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
32.28M 94.59M 221.19M
Short-Term Investments
49.94M 50.48M n/a
Long-Term Investments
187K 250K 312K
Other Long-Term Assets
21K 264K 1.17M
Receivables
12.69M 11.09M 5.69M
Inventory
12.44M 16.18M 3.47M
Other Current Assets
7.66M 7.16M 63K
Total Current Assets
114.95M 179.5M 243.56M
Property-Plant & Equipment
6.38M 7.95M 9.05M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
6.59M 8.46M 10.53M
Total Assets
121.54M 187.97M 254.09M
Account Payables
3.99M 7.43M 2.9M
Deferred Revenue
620K 7K 31K
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
8.2M 6.88M 5.16M
Total Current Liabilities
29.72M 35.59M 27.61M
Long-Term Debt
51.56M 77.02M 75.19M
Other Long-Term Liabilities
41K n/a n/a
Total Long-Term Liabilities
56.44M 83.63M 82.94M
Total Liabilities
86.15M 119.22M 110.55M
Total Debt
57.17M 83.77M 83.06M
Book Value
35.39M 68.75M 143.54M
Book Value Per Share
0.68 1.58 3.42
Common Stock
5K 5K 4K
Retained Earnings
-779.99M -732.02M -584.46M
Comprehensive Income
-0.00 -0.00 -0.00
Shareholders Equity
35.39M 68.75M -584.46M
Total Investments
50.13M 50.48M 312K